Approval · Notice of Compliance 4736 · 1996
HIVID: Notice of Compliance 4736
Issued January 30, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4736
- Date
- January 30, 1996
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for the use of the drug in monotherapy
- Therapeutic class
- Antiretroviral
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HIVID | Not yet assigned | — |
Medicinal ingredients
- ZALCITABINE 0.375 MG per TAB
- ZALCITABINE 0.75 MG per TAB